TransMedics TMDX
NASDAQ TMDX
$86.40 -1.87 (-2.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

TransMedics (TMDX) Free Cash Flow Growth (5y) (2023 - 2026)

Analysis

TransMedics (TMDX) Free Cash Flow Growth (5y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 TransMedics 2.98 Bn 2.51 Bn 113.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.36%
Mar 31, 2026 -10.53%
Dec 31, 2025 36.05%
Sep 30, 2025 63.20%
Jun 30, 2025 63.07%
Mar 31, 2025 -28.74%
Dec 31, 2024 23.18%
Sep 30, 2024 -49.00%
Jun 30, 2024 16.66%
Mar 31, 2024 -45.13%
Dec 31, 2023 -39.90%
Sep 30, 2023 -78.59%
Jun 30, 2023 0.78%
Mar 31, 2023 -8.52%